Annual report pursuant to Section 13 and 15(d)
Commitments and Contingencies (Details) $ in Millions |
Dec. 20, 2022
patent
|
Jan. 20, 2021
patent
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
---|---|---|---|---|
Commitments and Contingencies Disclosure [Abstract] | ||||
Purchase commitments | $ 1.0 | |||
Patent Infringement Complaint | ||||
Loss Contingencies [Line Items] | ||||
Number of patents allegedly infringed upon | patent | 1 | 2 | ||
Federal Healthcare Program Revenue | ||||
Loss Contingencies [Line Items] | ||||
Loss contingency accrual | $ 11.2 | $ 11.2 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of loss contingency liability. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of another entity's patents that the entity has allegedly infringed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|